Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | ![]() ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. | |
Founding Date | Founding Date 1878 | Founding Date 1993 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations San Diego, US HQ Princeton, US | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US |
Employees | Employees 4,955 | Employees 513 | Employees 141 |
Valuation ($) | Valuation ($) 12.3 b | Valuation ($) 2.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) ₹71.1m (FY, 2026) |
Cost of goods | Cost of goods ¥62.1b (FY, 2026) | Cost of goods $89m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥484.8b (FY, 2026) | Gross profit $982.5m (FY, 2025) | Gross profit ₹210.4m (FY, 2026) |
Net income | Net income ¥205.9b (FY, 2026) | Net income $391m (FY, 2025) | Net income (₹2.8b) (FY, 2026) |
Funding | |||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 770.8m | Total funding raised $ 32m |

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companySuven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS.
View company